DAWN SHAUM: Open Payments
NPI 1164855128 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,110 in 220 payments from 17 companies in 2025. Trend: 2023 $2,439 · 2024 $3,140 · 2025 $4,110
Food & beverage: $3,999Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $541 |
| Alkermes, Inc. | 27 | $525 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $443 |
| E.R. Squibb & Sons, L.L.C. | 26 | $443 |
| ABBVIE INC. | 32 | $332 |
| Teva Pharmaceuticals USA, Inc. | 12 | $319 |
| Vanda Pharmaceuticals Inc. | 10 | $239 |
| Axsome Therapeutics, Inc. | 5 | $203 |
| Neurocrine BioSciences, Inc. | 11 | $191 |
| Supernus Pharmaceuticals, Inc. | 16 | $175 |
Products named: ARISTADA, CAPLYTA, COBENFY, REXULTI, VRAYLAR, FANAPT, ABILIFY MAINTENA, Auvelity.
Industry payments across MI — which companies pay providers there.
